SCHEMBL23488371

SCHEMBL23488371

COC(=O)[C@H](CCCCNC(=O)CCCC(=O)Nc1cccc(COc2cc(OC)c(C(=O)O[C@H]3[C@@H](OC)O[C@H](CO)[C@@H](O)[C@@H]3O)cc2Cl)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 2/20 0.38
KLK5 Q9Y337 2/20 0.38
SIRT5 Q9NXA8 1/20 0.35
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LGALS9 O00182 1/20 0.32
LGALS1 P09382 1/20 0.32
LGALS3 P17931 1/20 0.32
LGALS7; LGALS7B P47929 1/20 0.32
SUV39H2 Q9H5I1 1/20 0.32
LGALS8 O00214 1/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
SIRT2 Q8IXJ6 2/20 0.31
SIRT1 Q96EB6 2/20 0.31
SIRT3 Q9NTG7 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488360 0.98 KLK7 (0.37) KLK7KLK5SIRT5KDM4EMAPT
SCHEMBL23488530 0.94 KLK7 (0.38) KLK7KLK5MAPTNPSR1TDP1
SCHEMBL23488505 0.93 LGALS9 (0.35) KLK7KLK5LGALS9LGALS1LGALS3
SCHEMBL23488341 0.92 KLK7 (0.38) KLK7KLK5MAPTNPSR1LGALS9
SCHEMBL23488345 0.92 KLK7 (0.39) KLK7KLK5SIRT5MAPTNPSR1
SCHEMBL23488210 0.91 KLK7 (0.38) KLK7KLK5MAPTNPSR1LGALS9
SCHEMBL23488617 0.91 KLK7 (0.37) KLK7KLK5SIRT5KDM4EMAPT
SCHEMBL23488379 0.89 KLK7 (0.36) KLK7KLK5SIRT5KDM4EMAPT
SCHEMBL23488776 0.89 KLK7 (0.36) KLK7KLK5SIRT5KDM4EMAPT
SCHEMBL23488246 0.89 KLK7 (0.36) KLK7KLK5SIRT5KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 KLK7 2859/4885KLK5 3345/4885SIRT5 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.